Literature DB >> 24900607

Potent oxazolidinone antibacterials with heteroaromatic C-ring substructure.

Hideyuki Suzuki1, Iwao Utsunomiya1, Koichi Shudo1, Takaji Fujimura2, Masakatsu Tsuji2, Issei Kato2, Toshiaki Aoki2, Akira Ino2, Tsutomu Iwaki2.   

Abstract

Novel oxazolidinone analogues bearing a condensed heteroaromatic ring as the C-ring substructure were synthesized as candidate antibacterial agents. Analogues 16 and 21 bearing imidazo[1,2-a]pyridine and 18 and 23 bearing [1,2,4]triazolo[1,5-a]pyridine as the C-ring had excellent in vitro antibacterial activities against methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecalis (VRE), and penicillin-resistant Streptococcus pneumoniae (PRSP). They also showed promising therapeutic effects in a mouse model of lethal infection. Preliminary safety data (inhibitory effects on cytochrome P450 isoforms and monoamine oxidases) were satisfactory. Further evaluation of 18 and 23 is ongoing.

Entities:  

Keywords:  Antibacterial; condensed heteroaromatic ring; methicillin-resistant Staphylococcus aureus; oxazolidinone

Year:  2013        PMID: 24900607      PMCID: PMC4027242          DOI: 10.1021/ml400280z

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  18 in total

1.  Penicillin-resistant Streptococcus pneumoniae: selection by both beta-lactam and non-beta-lactam antibiotics.

Authors:  F W Goldstein
Journal:  J Antimicrob Chemother       Date:  1999-08       Impact factor: 5.790

Review 2.  Antibacterial oxazolidinones: emerging structure-toxicity relationships.

Authors:  Adam R Renslo
Journal:  Expert Rev Anti Infect Ther       Date:  2010-05       Impact factor: 5.091

3.  Fitness cost of SCCmec and methicillin resistance levels in Staphylococcus aureus.

Authors:  Miriam Ender; Nadine McCallum; Rajan Adhikari; Brigitte Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

4.  Synthesis and SAR of novel oxazolidinones: discovery of ranbezolid.

Authors:  Biswajit Das; Sonali Rudra; Ajay Yadav; Abhijit Ray; A V S Raja Rao; A S S V Srinivas; Ajay Soni; Suman Saini; Shalini Shukla; Manisha Pandya; Pragya Bhateja; Sunita Malhotra; Tarun Mathur; S K Arora; Ashok Rattan; Anita Mehta
Journal:  Bioorg Med Chem Lett       Date:  2005-10-01       Impact factor: 2.823

Review 5.  Tuberculosis: the drug development pipeline at a glance.

Authors:  Baptiste Villemagne; Céline Crauste; Marion Flipo; Alain R Baulard; Benoit Déprez; Nicolas Willand
Journal:  Eur J Med Chem       Date:  2012-02-25       Impact factor: 6.514

6.  Vancomycin-resistant enterococci.

Authors:  A H Uttley; C H Collins; J Naidoo; R C George
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

Review 7.  Recent development of potent analogues of oxazolidinone antibacterial agents.

Authors:  Katarzyna Michalska; Izabela Karpiuk; Marek Król; Stefan Tyski
Journal:  Bioorg Med Chem       Date:  2012-12-05       Impact factor: 3.641

8.  Novel pyrazolo[1,5-a]pyridines as p110α-selective PI3 kinase inhibitors: Exploring the benzenesulfonohydrazide SAR.

Authors:  Jackie D Kendall; Anna C Giddens; Kit Yee Tsang; Raphaël Frédérick; Elaine S Marshall; Ripudaman Singh; Claire L Lill; Woo-Jeong Lee; Sharada Kolekar; Mindy Chao; Alisha Malik; Shuqiao Yu; Claire Chaussade; Christina Buchanan; Gordon W Rewcastle; Bruce C Baguley; Jack U Flanagan; Stephen M F Jamieson; William A Denny; Peter R Shepherd
Journal:  Bioorg Med Chem       Date:  2011-11-25       Impact factor: 3.641

Review 9.  Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.

Authors:  Françoise Van Bambeke; René R Reinert; Peter C Appelbaum; Paul M Tulkens; Willy E Peetermans
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Imidazo[1,2-a]pyridines. I. Synthesis and inotropic activity of new 5-imidazo[1,2-a]pyridinyl-2(1H)-pyridinone derivatives.

Authors:  M Yamanaka; K Miyake; S Suda; H Ohhara; T Ogawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1991-06       Impact factor: 1.645

View more
  3 in total

1.  Auranofin and related heterometallic gold(I)-thiolates as potent inhibitors of methicillin-resistant Staphylococcus aureus bacterial strains.

Authors:  Yozane Hokai; Boruch Jurkowicz; Jacob Fernández-Gallardo; Nuruddinkodja Zakirkhodjaev; Mercedes Sanaú; Theodore R Muth; María Contel
Journal:  J Inorg Biochem       Date:  2014-05-28       Impact factor: 4.155

2.  Design, Synthesis, and Antibacterial Evaluation of Oxazolidinones with Fused Heterocyclic C-Ring Substructure.

Authors:  Mahesh S Deshmukh; Nidhi Jain
Journal:  ACS Med Chem Lett       Date:  2017-09-28       Impact factor: 4.345

3.  Bifunctional phase-transfer catalysts for synthesis of 2-oxazolidinones from isocyanates and epoxides.

Authors:  Dong-Xiao Cui; Yue-Dan Li; Ping Huang; Zhuang Tian; Yan-Yan Jia; Ping-An Wang
Journal:  RSC Adv       Date:  2020-03-26       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.